药品价格登记系统上线 分析人士称或加速药企“出海”

Core Viewpoint - The launch of the Chinese Drug Price Registration System (referred to as "Drug Registration System") is expected to accelerate the internationalization of China's innovative drugs by providing a global, authoritative, standardized, and transparent market price registration platform [1][2]. Group 1: Overview of the Drug Registration System - The Drug Registration System is a national-level price registration platform independent of the medical insurance network, offering services such as price registration, price inquiry, price comparison, and notarization for drug marketing authorization holders [1]. - Pharmaceutical companies can autonomously declare and register drug prices based on their development needs, taking responsibility for the authenticity of the submitted information, while the operating unit only processes registration applications without intervening in pricing [1]. Group 2: Impact on the Pharmaceutical Industry - The establishment of the Drug Registration System is seen as a key measure to address the structural shortcomings in the pricing system, which has become a core bottleneck for companies seeking to internationalize [2]. - The platform aims to create a "one drug, one file" database covering innovative drugs and other registered varieties, providing authoritative support for companies to establish a consistent pricing system in domestic and international markets [2]. - Analysts believe that the Drug Registration System will promote the healthy development of China's pharmaceutical innovation ecosystem and facilitate high-quality internationalization, presenting long-term investment opportunities in the innovative drug sector [2].